Where does Roy Lobb work?

Roy Lobb is Venture Partner at Advent Life Sciences.

What check size does Roy Lobb write?

Roy Lobb typically writes checks of $25K – $5M.

What boards does Roy Lobb sit on?

Roy Lobb holds tracked board seats at Aleta Biotherapeutics.

What companies has Roy Lobb invested in?

Investments tracked here include Albor Biologics, Alvos Therapeutics, Avila Therapeutics.

Where did Roy Lobb go to school?

Roy Lobb studied at University of Oxford (DPhil, Chemistry).

Roy Lobb

Investor

Venture Partner at Advent Life Sciences

Massachusetts

Writes $25K – $5M checks · typically $1M

Find your path to Roy

46 people in our graph share verified history with Roy — schools, employers, funds. One of them is your warm intro.

Michael MoritzunlockedRoy: together at University of Oxford (1973–1974)

×11Roy: together at Advent Life Sciences

About

Roy Lobb joined Advent in 2015 with over 25 years of experience in drug discovery and development. He earned a D.Phil. from Oxford University and was previously an Assistant Professor of Pathology at Harvard Medical School, then spent 15 years at Biogen Inc, where he served as Senior Director of Exploratory Research and identified the pathway underlying the development of the multiple sclerosis drug Tysabri. Since leaving Biogen, he has cofounded several biotechnology companies.

Contact· self-published, not guessed

r•••@adventls.comreveal

Invests in

Biotech

Experience

Aleta Biotherapeuticsdirector and cofoundercurrent2015 — presentGreater Boston
Avila Therapeuticsconsultant & co-founder2007 — 2012
BiogenSenior director Discovery Research1987 — 2001

Investments

Board seats

Aleta Biotherapeutics

Investor

Albor BiologicsAlvos TherapeuticsAvila Therapeutics

Per the firm's website.

Colleagues at Advent Life Sciences

Alain Huriez

Venture Partner at Advent Life Sciences

Alan Walts

Venture Partner at Advent Life Sciences

Andrea Beesley

Team Assistant at Advent Life Sciences

Bonita Theara

Executive Assistant at Advent Life Sciences

Dale Pfost

Executive Officer at Advent Life Sciences

Dominic Schmidt

General Partner at Advent Life Sciences

Don Drakeman

Distinguished Research Professor, biotech entrepreneur, and venture partner

Fraser Murray

Head of Scientific Evaluation at Advent Life Sciences

Frequently asked questions

Who is Roy Lobb?: Roy Lobb joined Advent in 2015 with over 25 years of experience in drug discovery and development. He earned a D.Phil. from Oxford University and was previously an Assistant Professor of Pathology at Harvard Medical School, then spent 15 years at Biogen Inc, where he served as Senior Director of Exploratory Research and identified the pathway underlying the development of the multiple sclerosis drug Tysabri. Since leaving Biogen, he has cofounded several biotechnology companies.
Where does Roy Lobb work?: Roy Lobb is Venture Partner at Advent Life Sciences.
What does Roy Lobb invest in?: Roy Lobb invests in Biotech.
What check size does Roy Lobb write?: Roy Lobb typically writes checks of $25K – $5M.
What boards does Roy Lobb sit on?: Roy Lobb holds tracked board seats at Aleta Biotherapeutics.
What companies has Roy Lobb invested in?: Investments tracked here include Albor Biologics, Alvos Therapeutics, Avila Therapeutics.
Where did Roy Lobb go to school?: Roy Lobb studied at University of Oxford (DPhil, Chemistry).